Helping transform medical discovery and innovation into viable solutions that can impact the world



Maximizing Value

Understanding market needs. Learn More »»

Portfolio Planning

Balancing technical difficulty of development with commercial attractiveness. Learn More »»

Informatics in Molecular Medicine

The use of multi-methodology algorithms in medical practice today. Learn More »»

The Role of Impact Modeling

Establishing the “value” in high-value diagnostics. Learn More »»

Delivering Diagnostics for Global Health

Understanding needs and developing diagnostic solutions that improve linkage to care in low resource settings. Learn More »»

Point of Care Testing

Renewed interest in decentralized or Point of Care Testing: what’s changed?. Learn More »»

Consumer Digital and Mobile Health

Understanding regulatory, payment and education challenges in the consumer digital health space. Learn More »»

Latest News

Halteres Associates has published a new article blending Darwin’s “On the Origin of Species” with video production in biotech - “Pivot to Video: On The Origin of Views by Means of Video, or the Preservation of Favoured Companies in the Struggle for Engagement - and What That Means for the Diagnostics Industry”.  Click here to read the article

The Halteres Associates video production team has wrapped another video production project! Many clients have asked what exactly goes into a day on set, so here is a peek behind the scenes!   learn more

It has been announced that Mickey Urdea will be giving a virtual keynote speech for SelectBIO’s conference on “Microfluidics to Address Pandemics – SARS-CoV-2 and Beyond”, which takes place in the Netherlands March 1st-2nd, 2022.

This 2-day conference held onsite as a regular physical conference at the Hilton Rotterdam, The Netherlands, takes a deep dive on the current role of Microfluidics Technologies in SARS-CoV-2 testing (circa 2022) and expectations for the future role of Microfluidics in the Management of Pandemics.

The conference brings together companies engaged in this space from the larger diagnostics companies to the emerging companies providing technical solutions in this field -- providing them a platform to present their technology/offering to the community and engage.

In addition to presentations, there will be posters to highlight technologies and late-breaking developments.

This conference is chaired by Dr. Holger Becker, Chief Scientific Officer and Co-Founder of microfluidic ChipShop GmbH and a key opinion leader in the microfluidics and lab-on-a-chip field.



  • Business and Financial Modeling
  • Business Development
  • Clinical Studies and Regulatory
  • Global Sales and Marketing
  • Impact Modeling and Value Creation
  • Intellectual Property
  • Investor Presentations
  • Market and Technology Assessments
  • Medical Practice
  • Portfolio Planning
  • Product and Process Development
  • Strategic and Tactical Planning


  • Algorithms / Informatics / Health IT
  • Biomarker Discovery and Validation
  • Biostatistics
  • Companion Diagnostics
  • Digital Health and Wellness
  • Histology / Anatomic and Clinical Pathology
  • Immunodiagnostics
  • Instrument Systems
  • Life Science Research Tools
  • Medical Devices
  • Molecular Diagnostics
  • Next Generation Sequencing


  • Blood Screening
  • Chronic Diseases
  • Clinical Laboratory Services
  • Global Health
  • Infectious and Chronic Diseases
  • Life Science Research
  • Oncology
  • “Omics” applications
  • Parasitology
  • Pathology
  • Point of Care Testing
Scroll to Top